T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Other Current Liabilities
ÂĄ10.1m
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Current Liabilities
ÂĄ2.1B
CAGR 3-Years
57%
CAGR 5-Years
29%
CAGR 10-Years
26%
Proya Cosmetics Co Ltd
SSE:603605
Other Current Liabilities
ÂĄ475.8m
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Other Current Liabilities
ÂĄ611m
CAGR 3-Years
79%
CAGR 5-Years
33%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Current Liabilities
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
18%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Current Liabilities
ÂĄ230.7m
CAGR 3-Years
-51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Other Current Liabilities?
Other Current Liabilities
10.1m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Other Current Liabilities amounts to 10.1m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
5%

Over the last year, the Other Current Liabilities growth was -70%.

Back to Top